The Medicines Co (MDCO.O)
7.83USD
1:56pm EST
$0.01 (+0.13%)
$7.82
$7.83
$7.90
$7.70
58,923
352,802
$16.77
$6.15
MDCO.O
About
Overall
| Beta: | 0.73 |
| Market Cap (Mil.): | $413.45 |
| Shares Outstanding (Mil.): | 52.87 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| MDCO.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 3.55 | 4.61 |
| EPS (TTM): | -141.94 | -- | -- |
| ROI: | -2.18 | 1.82 | 2.82 |
| ROE: | -2.29 | 2.44 | 4.12 |
Medicines Co. blood thinner still has hope: doctors
* Say lower mortality, stent clots justify further study
CORRECTED - CORRECTED-BUY OR SELL-Will Angiomax generics clot Medicines' sal
(Corrects to remove reference to company's pipeline being dead, attributed to RBC analyst Jason Kantor in penultimate paragraph. The analyst was misquoted) (For more Reuters BUY OR SELL stories, click [BUYSELL/])
HEADLINE STOCKS-Some U.S. stocks on the move on Aug. 31
(Updates to after the open, adds Disney/Marvel, Merck, Medicines, Crosstex, Constellation and BorgWarner)
BEFORE THE BELL-Medicines up after comments on drug
NEW YORK, Aug 31 (Reuters) - Shares of Medicines Co rose 9.5 percent to $8.29 in premarket trading on Monday after the company said its anticlotting drug improved overall survival in patients who had suffered the most severe form of heart attack and received angioplasty.
UPDATE 1-Medicines Co's drug improves survival in heart patients
* Drug shows absolute reduction of 1.7 pct in cardiac death
UPDATE 1-Medicines Co withdraws European application for drug
Aug 20 (Reuters) - Medicines Co said it withdrew the European marketing application for its experimental antibiotic, oritavancin, after the European Medicines Agency indicated that another trial would be required before approval could be considered.
UPDATE 2-Medicines Co Q2 profit beats Street, cuts '09 rev view
* Cuts '09 rev range to $430-$455 mln from $435-$464 mln
CORRECTED - CORRECTED-(May 13)-UPDATE 3-Medicines Co stops anticlotting tria
(Corrects paragraph 16 in May 13 story to clarify that the company could, and not would, retain pediatric exclusivity till September 2010)
HEADLINE STOCKS-U.S. stocks on the move on May 14
(Updates to after the open, adds Urban Outfitters, Ford, General Dynamics, Lear and PNC Financial)
HEADLINE STOCKS-U.S. stocks to watch on May 14
NEW YORK, May 14 (Reuters) - Some U.S. stocks to watch on Thursday:
Competitors
| Price | Change | |
|---|---|---|
| GlaxoSmithKline plc (GSK.L) | £1,303.00 | +5.00 |
| Bayer AG (BAYGn.DE) | €54.43 | +1.02 |
| Bayer AG (BAYE.F) | -- | -- |
| Encysive Pharmaceuticals, Inc. (ENCY.OQ) | -- | -- |
| Sanofi-Aventis SA (SASY.PA) | €52.70 | -0.20 |
| Eisai Co., Ltd (4523.T) | ¥3,340.00 | +70.00 |
| Pfizer Inc. (PFE.N) | $18.39 | +0.07 |
| Eli Lilly & Co. (LLY.N) | $34.87 | -0.15 |
| Johnson & Johnson (JNJ.N) | $64.96 | +0.19 |
| Schering-Plough Corporation (SGP.N) | -- | -- |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
